Category: news

Aaron speaks at the 2023 International Academy for Advanced Oncology meeting in Tokyo. Thanks to Dr. Nori Takanashi and Dr. Taro Mizayaki and C-FINDS for their hospitality and organizing such a terrific meeting! Such a great opportunity to make new Japanese friends and reconnect with MGH alumns Dr. Aya Shiba (Hata Lab), Dr. Ryohei Katayama (Engelman Lab) and Dr. Hiro Ebi (Engelman Lab).

We say farewell to Susanna who will be attending NYU for a PhD in Chemistry. Best wishes to you in your future endeavors – we will miss you!

MGB Press Release: “Mass General Cancer Center Researchers Pinpoint Protein Tied to Drug Resistance in Patients with Lung Cancer.”

Hideko’s manuscript “Therapy-induced APOBEC3A drives evolution of persistent cancer cells” is now published in Nature! We show that lung cancer targeted therapies induced APOBEC3A, which drives evolution of drug tolerance and resistance. This was terrific collaborative effort with the Lawrence Group, Dyson Lab, Zou Lab, Ott Lab, Getz Lab, MGH Thoracic Oncology and many others.

We say farewell to Sarah who will be attending Yale University as a graduate student. Best wishes to you in your future endeavors – we will miss you!

Aaron teamed up with ALK NSCLC advocate and patient Colleen Ziegler at CenterStage 2023 at the MFA to highlight the importance of “bedside-to-bench” research at the MGH Cancer Center.

AACR Annual Meeting 2023: Chendi presents her posters “Chromatin modification driving sub-clonal resistance to KRAS G12C combination therapies in KRAS mutant non-small cell lung cancer” and “Aurora kinase A inhibition overcome adaptive resistance to KRAS G12C inhibitor by G1-checkpoint induced apoptosis in KRAS non-small cell lung cancer.”

AACR Annual Meeting 2023: Hideko presents her poster “Epigenetic regulation of APOBEC3A mutagenesis and tumor evolution during targeted therapy in non-small cell lung cancer.”

Congratulations to Wafa for passing her Preliminary Qualifying Exam for the Harvard BBS Program today!